Form 8-K - Current report:
SEC Accession No. 0000950170-24-112899
Filing Date
2024-10-04
Accepted
2024-10-04 16:05:09
Documents
11
Period of Report
2024-10-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ktra-20241004.htm   iXBRL 8-K 101657
  Complete submission text file 0000950170-24-112899.txt   225559

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ktra-20241004.xsd EX-101.SCH 27217
13 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20241004_htm.xml XML 4909
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 241354921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)